Reactive arthritis following BCG immunotherapy for bladder carcinoma

Clinical Rheumatology

Volumn 24, Issue 4, 2005, Pages 425-427

  Tinazzi, Elisa ^a   Ficarra, Vincenzo ^a   Simeoni, Sara ^a   Peterlana, Dimitri ^a   Lunardi, Claudio ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTHRALGIA; ARTHRITIS; ARTHROCENTESIS; ARTICLE; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CASE REPORT; CYSTITIS; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; FOLLOW UP; HEMATURIA; HIGH RISK PATIENT; HUMAN; LEUKOCYTOSIS; MALAISE; MALE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVESICAL; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, REACTIVE; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; MALE; NEOPLASM STAGING; RISK ASSESSMENT; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 23344453674     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1063-8     Document Type: Article

References (31)

1. Morales A, Nickel JG (1986) Immunotherapy of superficial bladder cancer with BCG. World J Urol 3:209-214
2. Lamm DL (2000) Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer. Clin Infect Dis 31:S86-S90
3. Talic RF, Hargreave TB, Bishop MC, Kirk D, Prescott S (1994) Intravesical Evans bacille Calmette-Guerin for carcinoma in situ of the urinary bladder. Scottish Urological Oncology Group. Br J Urol 73:645-648
4. Hurle R, Losa A, Manzetti A, Lembo A (1999) Intravesical bacille Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: A 7-year follow-up. Urology 54:258-263
5. Herr HW, Sogani PC (2001) Does early cystectomy improve the survivals of patients with high risk superficial bladder tumors? J Urol 166:1296-1299
6. Lamm DL, Van der Meijden ADPM, Morales A et al (1992) Incidence and treatment of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 147:596-600
7. Jackson AM, Alexandroff AB, Kelly RW et al (1995) Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guerin (BCG) immunotherapy. Clin Exp Immunol 99:369-375
8. Saint F, Patard JJ, Maille P et al (2001) T-helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer. J Urol 166:2142-2147
9. Pardalidis NP, Papatsoris AG, Kosmaoglou EV, Georganas C (2002) Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer. Clin Rheumatol 21 536-537
10. Mas AJ, Romera M, Valverde-Garcia JM (2002) Articular manifestations after the administration of intravesical BCG. Joint Bone Spine 69:92-93
11. Satoh A, Hanawa Y, Nakamura S (2004) Clinical study of bladder cancer: proteinuria as a predictor of recurrence and efficacy of intravesical bacille Calmette-Guerin therapy. Int J Urol 11:476-482
12. Onur O, Celiker R (1999) Polyarthritis as a complication of intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer. Clin Rheumatol 18:74-76
13. Shoenfeld Y, Aron-Maor A, Tanai A, Ehrenfeld M (2001) BCG and autoimmunity: Another two-edged sword. J Autoimmun 16:235-240
14. Pego JM, Lamas C, Hernandez I, Suso J (2003) Relapsing Reiter's syndrome after bacillus Calmette-Guerin immunotherapy for bladder carcinoma. Med Clin 121:356-357
15. Narvaez J, Castro-Bohorquez FJ, Vilaseca-Momplet J (2003) Sjögren's-like syndrome following intravesical bacillus Calmette-Guerin immunotherapy. Am J Med 115:418-419
16. Lunardi C, Bason C, Navone R et al (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183-1186 10.1038/80533
17. Pearson CM (1964) Experimental models in rheumatoid disease. Arthritis Rheum 7:80-86
18. Buchs N, Chevrel G, Miossec P (1998) Bacillus Calmette-Guerin induced aseptic arthritis: An experimental model of reactive arthritis. J Rheumatol 25:1662-1665
19. Dulphy N, Peyrat M-A, Tieng V et al (1999) Common intra-articular T cell expansions in patients with reactive arthritis: Identical αchain junctional sequences and cytotoxicity toward HLA-B27. J Immunol 162:3830-3839
20. Shoenfeld Y, Vilner Y, Coates ARM, Rauch J, Shaul D, Pinkhas J (1986) Monoclonal antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255-261
21. Thorns CJ, Morris JA (1985) Common epitopes between mycobacteria and certain host tissue antigens. Clin Exp Immunol 61:323-328
22. Prescott S, Jackson AM, Hawkyard SJ, Alexandroff AB, James K (2000) Mechanisms of action of intravesical bacille Calmette Guerin: Local immune mechanisms. Clin Infect Dis 31 [Suppl 3]:S91-S93
23. Lindqvist KJ, Coleman RE, Osterland CK (1997) Autoantibodies in chronic pulmonary tuberculosis. J Chron Dis 22:717-725
24. Glynn P, Weedon D, Edwards J, Suckling AJ, Cuzner ML (1982) Humoral immunity in chronic relapsing experimental autoimmune encephalomyelitis. The major oligoclonal IgG bands are antibodies to mycobacteria. Neurol Sci 57:369-384
25. Van Eden W, Holoshitz J, Nevo A, Frenkel A, Klajman A, Cohen IR (1985) Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A 82:5117-5120
26. Holoshitz J, Naparstek Y, Ben-Nun A, Cohen IR (1983) Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 219:56-58
27. Pockley AG (2003) Heat shock proteins as regulators of the immune response. Lancet 362:469-476
28. Wick G, Perschinka H, Millonig G (2001) Atherosclerosis as an autoimmune disease: An update. Trends Immunol 22:665-669
29. Zugel U, Schoel B, Yamamoto S, Hengel H, Morein B, Kaufmann SH (1995) Crossrecognition by CD8 T cell receptor alpha beta cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology. Eur J Immunol 25:451-458
30. Lamm DL, Stodgill VD, Stodgill BJ, Crispen RG (1986) Complications of bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J Urol 135:272-274
31. de Boer LC, Steerenberg PA, van der Meijen APM et al (1992) Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig. J Urol 148:1577-1582